drugset / Trial / NCT03658330
Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
NaSingle-groupOpen-labelTreatment
Summary
To evaluate if naltrexone plus ketamine is effective in reducing depression and alcohol consumption.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-10
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |
| Subject | Naltrexone | Small molecule | 380 mg | Intramuscular |